Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of current GLP-1 drugs. By shifting focus from neurons to brain support cells that produce appetite-suppressing molecules, they developed a modified compound, TDN, that worked in animal tests without causing nausea or vomiting.